ipodate calcium (oragrafin calcium) Report issue

Small molecule Approved FDA Priority Review FDA
ChEMBL Drug Central Drugs@FDA PubChem

Active Ingredient History

NOW
  • Now

Chemistry

  • SMILES: [Ca+2].CN(C)\C=N\c1c(I)cc(I)c(CCC(=O)[O-])c1I.CN(C)\C=N\c2c(I)cc(I)c(CCC(=O)[O-])c2I
  • InChIKey: HVZGHKKROPCBDE-HZIJXFFPSA-L
  • Mol. Mass: 1233.98
  • ALogP: 3.74
  • ChEMBL Molecule:
    ipodate calcium  
More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Discontinued
  • Delivery Methods: Oral
  • Pro Drug: No

Alternative names

calcium iopodate | ipodate calcium | oragrafin calcium

Organizations (1)

Research & Development (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (1)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (1)

Approved Indications (1)


 

Diagnostic Imaging (approved 1962)

Experimental Indications - Clinical Trial Phases 1-4 (0)

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue